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Abstract
Bacterial secondary metabolites are widely used as antibiotics, anticancer drugs, insecticides and food additives. Attempts to
engineer their biosynthetic gene clusters (BGCs) to produce unnatural metabolites with improved properties are often
frustrated by the unpredictability and complexity of the enzymes that synthesize these molecules, suggesting that genetic
changes within BGCs are limited by specific constraints. Here, by performing a systematic computational analysis of BGC
evolution, we derive evidence for three findings that shed light on the ways in which, despite these constraints, nature
successfully invents new molecules: 1) BGCs for complex molecules often evolve through the successive merger of smaller
sub-clusters, which function as independent evolutionary entities. 2) An important subset of polyketide synthases and
nonribosomal peptide synthetases evolve by concerted evolution, which generates sets of sequence-homogenized domains
that may hold promise for engineering efforts since they exhibit a high degree of functional interoperability, 3) Individual BGC
families evolve in distinct ways, suggesting that design strategies should take into account family-specific functional
constraints. These findings suggest novel strategies for using synthetic biology to rationally engineer biosynthetic pathways.
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Introduction
Bacterial secondary metabolites are widely used as pharmaceu-
tical, agricultural, and dietary agents. They consist of many classes
of compounds including polyketides (PKs), nonribosomal peptides
(NRPs), ribosomally synthesized and post-translationally modified
peptides (RiPPs), terpenoids, saccharides, and a plethora of
hybrids. The genetic basis for this rich molecular diversity can
be found in biosynthetic gene clusters (BGCs), physically clustered
groups of genes that encode the enzymatic pathways necessary to
construct specific chemicals [1,2].
The diversity of extant natural products and BGCs raises
important questions about their evolutionary origin. These include
the basic question of how Nature invents new molecules, and a
series of applied questions relevant to biotechnology: for example,
the evolutionary modularity of NRP and PK BGCs has long been
seen as a feature that might allow large libraries of new compounds
to be generated by mixing and matching their constituent domains
and modules [3]. However, although there have been notable
successes [4–6], the majority of combinatorially generated pathways
appear to be nonfunctional [4]. More recently, advanced synthetic
biology approaches to pathway engineering have been frustrated by
the complexity and unpredictability of metabolic enzymes, partic-
ularly NRPSs and PKSs [7,8]: unlike LEGO bricks, their
constituent domains and modules do not ‘fit’ together universally,
but only function effectively in specific pathway contexts.
Regardless of these apparent constraints to genetic change,
Nature appears to have been quite successful at engineering
biosynthetic pathways through the process of gene cluster
evolution: even a conservative estimate suggests that the number
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of broad biosynthetic gene cluster families that have evolved
exceeds 6,000 [8], most of which contain multiple BGCs that
synthesize derivatives of a common scaffold. Hence, a detailed
study of evolutionary patterns within various BGC families has the
potential to offer a new inroad into effective BGC engineering,
through mimicry of Nature’s evolutionary design strategies.
So far, insights into the key principles underlying the evolution
of BGC architectures and repertoires have been derived from
limited case studies [9–13], which lack sufficient detail about the
generality of the underlying mechanisms. Here, we systematically
quantify the strategies that make evolution so successful at
engineering BGC diversity. Through a detailed computational
analysis of a recently generated dataset of 732 known and 10,724
predicted prokaryotic BGCs [8], we find that the rates of
evolutionary events, such as insertions, deletions and duplications
within BGCs, are much higher than those seen in comparable
gene clusters involved in primary metabolism. Furthermore,
distinct sub-clusters consisting of co-evolving genes appear to
constitute relatively independent building blocks that play key
roles in the evolution of larger BGCs encoding the biosynthesis of
complex metabolites. Finally, BGC families encoding the produc-
tion of polyketides and nonribosomal peptides evolve in family-
specific modes, in many of which we observe an unexpectedly
large role for concerted evolution [14,15] driven by internal
recombinations. Based on these observations, we offer several
recommendations for establishing new modes of evolution-guided
BGC engineering.
Results/Discussion
BGCs are rapidly evolving genomic entities
The large diversity of BGCs observed throughout the prokary-
otic tree of life [8] suggests that BGCs evolve rapidly. Indeed,
when we systematically quantified different evolutionary events by
mutually comparing all gene clusters in our data set (Table S1),
we found not only that they may have been transferred
horizontally at high frequency (Fig. 1a and Figure S1), but
also display exceptionally high rates of insertions, deletions,
duplications and rearrangements (Fig. 1b). While the percentage
of gene cluster pairs related by an indel is independent of gene
cluster size, the distribution of indel sizes shows a long tail that
includes 195 indels of 10 kb or more (Fig. 1c). As expected, these
large indels are more commonly found in larger gene clusters,
where they indicate either the merger of one gene cluster fragment
with another or the loss of a gene cluster fragment from a larger
cluster (see examples in Figure S2). Phylogenetic profiling [16]
showed that many such BGC fragments – here termed sub-clusters
– appear to evolve in a correlated fashion: 884 different motifs of
adjacent Pfam domains (out of 7,641 found) were shown to co-
evolve significantly more often than not (P,0.001), based on the
x2 test. These motifs comprise 591 different Pfam domains and
have an average length of 5.3 domains (Table S2). As expected,
they include many well-known and widely conserved motifs that
appear to be linked to specific sub-functionalities of gene clusters,
such as precursor biosynthesis, transport or synthesis of a specific
chemical moiety, and motifs belonging to modular BGC
architectures of NRPSs and PKSs (e.g., C-A-T and KS-AT-T
[17]).
Sub-cluster sharing enables evolutionary
‘recombineering’ of BGCs
Earlier evidence has suggested complex mosaic patterns of sub-
cluster sharing for some BGCs, such as those involved in the
production of glycopeptides [18]. To further explore the role of
sub-cluster sharing in the evolution of BGCs, we manually
compiled a set of 35 BGCs that are rich in sub-clusters that have
a known connection with a specific chemical moiety. We then used
this data set to construct a network in which the nodes represent
BGCs and the edges denote a sub-cluster that a pair of BGCs has
in common (Fig. 2). Three observations were particularly notable
(Fig. 2). First, .60% of the coding capacity of some BGCs (e.g.,
those encoding vancomycin and rubradirin [19]) is composed of
individually conserved sub-clusters (note that this is not entirely
reflected in the depiction of the rubradirin gene cluster in Fig. 2b,
where only those sub-clusters are highlighted that are shared with
other depicted BGCs). This supports a ‘‘bricks and mortar’’ model
of gene cluster evolution in which gene clusters are composed of
large, modular ‘‘bricks’’ (sub-clusters) that encode key building
blocks and individual genes (the ‘‘mortar’’) that encode functions
such as tailoring, regulation and transport. During evolution, both
bricks and mortar (scaffold and tailoring) may remain the same,
only the tailoring may change or the scaffold itself may change.
Second, the same sub-cluster commonly appears in otherwise
unrelated BGCs, and multiple unrelated sub-clusters can be found
in a single parent gene cluster, indicating that sub-clusters are
independent evolutionary entities. Third, sub-clusters are not
static; they are loosely organized around a core set of genes, but
gene gain/loss leads to chemical changes in the corresponding part
structure: for example, gene clusters encoding molecules such as
everninomicin [20], simocyclinone [21] and polyketomycin [22]
have different variants of deoxysugar sub-clusters, which lead to
subtle variations in the final chemical structures.
Although the complex patterns of sub-cluster sharing, in which
various sub-clusters are shared between otherwise completely
different gene clusters (Fig. 2), indicate that BGCs may evolve by
the successive merger of sub-clusters, this does not mean that every
case where sub-clusters are shared points to an independent sub-
cluster transfer event. For example, the KS domains of the diverse
range of ansamycin type I PKS BGCs that harbor AHBA sub-
clusters are almost completely monophyletic (Figure S3),
indicating that the macrolactam- and AHBA-producing sub-
clusters have been co-evolving for a long time (instead of multiple
Author Summary
Bacterial secondary metabolites mediate a broad range of
microbe-microbe and microbe-host interactions, and are
widely used in human medicine, agriculture and manufac-
turing. Despite recent advances in synthetic biology,
efforts to engineer their biosynthetic genes for the
production of unnatural variants are frustrated by a high
failure rate. In an effort to better understand what types of
genetic changes are most likely to lead to successful
improvements, we systematically analyzed the ways in
which biosynthetic genes naturally evolve to generate new
compounds. We show that large gene clusters appear to
evolve through the merger of sub-clusters, which function
independently, and are promising units for cluster engi-
neering. Moreover, a subset of gene clusters evolve by
concerted evolution, which generates sets of interoperable
domains that may enable predictable domain swapping.
Finally, many biosynthetic gene clusters evolve in family-
specific modes that differ greatly from each other. Overall,
this quantitative perspective on the ways in which gene
clusters naturally evolve suggests novel strategies for
using synthetic biology to engineer the production of
unnatural metabolites.
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independent AHBA sub-cluster acquisitions having occurred in
different macrolactam-producing polyketide BGCs). Hence, the
multi-hybrid rubradirin gene cluster might have arisen from a
rifamycin-like ancestor (most rubradirin KS domains are mono-
phyletic with rifamycin KS domains, see Figure S3) that already
harbored the combination of a modular type I PKS sub-cluster
and an AHBA biosynthesis sub-cluster, and which then acquired
new sub-clusters for the biosynthesis of the aminocoumarin, 3,4-
dihydroxydipicolinate and nitrosugar moieties (which are not
found in any other closely related ansamycins). Contrary to the
shared evolutionary histories of AHBA and ansamycin type I PKS
sub-clusters, a clear example of sub-cluster transfer between BGCs
of different types can be seen for 6-methylsalicylic acid (MSAS)/
orsellinic acid (OSAS) sub-clusters, as inferred from a maximum-
likelihood phylogenetic tree of MSAS/OSAS-producing iterative
PKSs (Figure S4). The topology of this tree strongly indicates that
MSAS/OSAS sub-clusters have largely evolved independent of
the scaffold types of their parent gene clusters (Figure S4), and
that they have been transferred between multiple types of BGCs
during their evolutionary past. In conclusion, in the context of the
bricks-and-mortar analogy, some bricks move around between
different structures more often than others. Finally, we should note
that there are also BGC families which evolve over long periods of
time without major changes to the gene cluster architecture or the
scaffold of the core molecule made: for example, the large family
of over .1,000 aryl polyene BGCs that we described recently [8]
has not undergone any major sub-cluster transfers, aside from the
inclusion of the dialkylresorcinol sub-cluster in the BGCs from
some CFB group bacteria. The products of many of these BGCs
are likely to be entirely identical, while remaining differences
between the molecules mostly concern differential tailoring of the
same scaffold.
Evolution from one scaffold to another
Many chemical scaffold types of secondary metabolite classes
are quite distinct, which raises the question of how BGC families
encoding the synthesis of distinct scaffolds are related. To assess
this question, we calculated the proportion and similarity of Pfam
domains shared between all pairs of BGCs within our data set of
732 known gene clusters using multiple sequence alignments for
each Pfam domain (Fig. 3) and looked specifically for close
homologues of BGCs just outside their immediate family. Even
though of course sequence similarity alone does not provide
conclusive evidence on evolutionary histories, the analysis did
suggest that unexpected evolutionary connections might exist
between natural products of different scaffold types.
For example, the Streptomyces gene cluster encoding the
lipopeptide antibiotic daptomycin [23] is surprisingly similar to
Mycobacterium glycopeptidolipid (GPL) gene clusters [24] (Figure
S5). When we performed a more in-depth analysis through a
phylogenetic analysis of condensation domains, we indeed found
that GPL domains consistently cluster together with domains from
the NRPSs that synthesize daptomycin (Figure S6). Although
both daptomycin and the GPLs are lipopeptides, the Mycobacte-
rium GPLs are shorter (tetrapeptide vs. tridecapeptide), cell-wall-
associated rather than diffusible, linear rather than cyclic, and
originate from an actinomycete genus that is not closely related to
Streptomyces.
Likewise, one of the strongest matches for the gene cluster
encoding the immunosuppressant rapamycin [25], apart from the
closely related FK520 [26] and meridamycin [27,28] BGCs, was
the gene cluster for pladienolide [29], a polyketide of unrelated
structure with a distinct biological activity (inhibition of the
splicing factor SF3b instead of TOR). Strikingly, based on
phylogenetic trees of their constituent ketosynthase (KS) and
Figure 1. The rapid and dynamic evolution of BGCs differs from the evolution of ribosomal gene clusters and primary metabolism.
a, Distributions of the best matching sequence homologs with respect to organism similarity (based on 16S rRNA) for predicted BGCs and histidine
operons suggest significant differences in the ways they evolve. b, Number of detected rearrangements, indels and duplications plotted against the
average percent identity in the aligned gene cluster pairs from which the events were deduced for predicted BGCs (top) and ribosomal gene clusters
(bottom). Ribosomal gene clusters were selected for comparison based on their relatively large sizes (,10–15 kb) compared to primary metabolic
operons; to obtain a fair comparison with BGCs, only gene clusters of sizes 5–15 kb were taken into account. Counts are based on a systematic
comparison of all gene clusters in our data set that share regions of.1000 bp with.70% identity, in which events were inferred from alignments of
such 1000 bp blocks. Of the 10,096 BGC pairs meeting these criteria, 1,750 had a rearrangement, 1,140 had an indel, and 135 had a duplication, each
of which were far more common than the corresponding evolutionary events in gene clusters encoding the translation apparatus. Interestingly, while
indels and rearrangements could be detected in ,16% and ,19% of BGCs of all sizes, duplications are found far more commonly in gene clusters
with sizes of .40 kb (7.6%) than in gene clusters with sizes of 10–20 kb (0.3%), suggesting a possible role for duplication and divergence in the
evolution of large gene clusters. c, Size distribution of inserted/deleted fragments during recent gene cluster evolution, based on the indel analysis.
doi:10.1371/journal.pcbi.1004016.g001
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Figure 2. Complex BGC architectures evolve through new combinations of sub-clusters that are shared between multiple gene
cluster types. a, Network of sub-clusters shared among 34 known BGCs. Nodes represent BGCs, and node size indicates the number of sub-clusters
present in the gene cluster that are shared with other BGCs within the network. Edges represent shared sub-clusters, coded by color. The pattern of
sharing indicates that many sub-clusters are regularly transferred between BGCs of different types. In the interpretation of this analysis, it should be
kept in mind that in rare cases different biosynthetic routes (and hence, different sub-clusters) exist towards the same moiety. b, A sub-network from
a showing the shared sub-clusters among the BGCs for rubradirin, rifamycin, simocyclinone, everninomicin, and polyketomycin, as well as the
chemical moieties encoded by the sub-clusters.
doi:10.1371/journal.pcbi.1004016.g002
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acyltransferase (AT) domains, the meridamycin gene cluster is
more closely related to the pladienolide BGC than to those
encoding rapamycin and FK520, the molecules to which it is often
compared (Fig. 3). These examples suggest that closely related
sets of protein domains can be reconfigured by evolution to yield a
new scaffold that is chemically and biologically distinct.
Figure 3. Unexpected evolutionary relationships within the rapamycin family. a, Distinct scaffolds produced by pathways from related
BGCs. The scatter plot shows the relationship between the sequence homology of a pair of BGCs (x-axis) and the structural homology of their small
molecule products (y-axis), compared to rapamycin and its BGC. Each circle represents a gene cluster and its small molecule product. Meridamycin
and FK520 are closely related to rapamycin, as are their BGCs. While the pladienolide BGC is closely related to the rapamycin BGC, the structure of
pladienolide itself is not very similar to that of rapamycin. In particular, pladienolide has a much smaller macrocycle and lacks shikimate- or
pipecolate-derived moieties, and, as a result, binds to a distinct protein target. Structural similarity is estimated by the Tanimoto coefficient using
linear-path fingerprints (FP2) from Open Babel [67], while sequence homology is represented as the Jaccard index defined on pairs of Pfam domains
that share sequence identities within the top 10th percentile of all-pair sequence identities. The number of domain pairs that share sequence
identities within the top 10th percentile and sequence identity of all domain pairs are shown as point sizes and colors, respectively. b, The role of
concerted evolution in homogenizing domains within a BGC. Phylogenetic trees of KS and AT domains from the rapamycin, FK520, meridamycin, and
pladienolide BGCs are shown (for detailed trees with accession numbers and bootstrap values, see Figure S11). The KS and AT sequences largely
cluster into BGC-specific clades; for the AT domains, this is even the case for two different clusters encoding the same compound (meridamycin),
showing the ability of concerted evolution to homogenize domains within a BGC. c, Chemical structures of rapamycin, meridamycin, FK520 and
pladienolide. The sub-structure shared among rapamycin, meridamycin and FK520 is colored red, and the domains responsible for the biosynthesis of
this sub-structure in each molecule are indicated with red circles in b.
doi:10.1371/journal.pcbi.1004016.g003
Computational Analysis of Biosynthetic Gene Cluster Evolution
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Concerted evolution in the rapamycin family
The phylogenetic trees of KS and AT domains from our data
set of known BGCs revealed another unexpected finding: in spite
of the structural similarity of rapamycin and FK520, 63% of the
constituent domains of their polyketide synthases (PKSs) cluster
into entirely separate clades (Fig. 3b, see also Figure S8 which
shows that relevant bootstrap values are almost all above 90). Even
more remarkably, 14 out of 16 domains responsible for the
biosynthesis of the sub-structure shared between these two
molecules (shown in red in Fig. 3c) do not cluster together with
the corresponding domain from the assembly line for the other
molecule. This pattern of homology is consistent with a
phenomenon called ‘concerted evolution’, the homogenization of
DNA sequences within a given repetitive family caused by high
rates of internal recombination [14,15]. Given the similar sizes and
architectures of the gene clusters and the structural similarity of
their products, this is a much more parsimonious explanation for
the patterns observed than convergent evolution of multiple
similar gene clusters through successive duplication of an ancestral
single-module PKS. Notably, previous phylogenetic analyses of
PKS domains have also observed BGC-specific clades of PKS
domains [10,30], but not to the extent observed here for such
closely related gene clusters: the fact that such a strong pattern is
even observed for the AT domains of two different gene clusters
that encode the same molecule [27,28], meridamycin, shows that
the underlying process may operate on very short time scales, and
that recombination can remove almost all traces of independent
evolution of these PKS modules. In the case of the rapamycin
family, recombinations are likely to occur neutrally and have no
effect on the structure of the small molecule product (rapamycin,
meridamycin and FK520), whereas in other cases, single
crossovers within or between gene clusters may dramatically
change the modular architecture of a synthase [30]. Near-neutral
changes brought about by gene conversion may occur at higher
rates for some domains or domain types than for others: in the
meridamycin gene clusters, no signs of gene conversion could (yet)
be observed for KS domains, even though gene conversion
manifested itself clearly when comparing the meridamycin clusters
with those encoding rapamycin, FK520 and pladienolide. On the
contrary, AT domain gene conversion was widespread even
between the two meridamycin gene clusters. We speculate that for
these BGCs, gene conversion events get fixated in the population
at lower rates for KS domains because not all KS sequences work
equally well for different polyketide chain lengths that occur at
different points of the assembly line, so that the changes brought
about by a conversion event are less neutral than for AT domains.
Mapping of rapamycin family PKS sequence mutations onto the
3D structure of an AT- and KS-containing protein further
supports this hypothesis (Figure S7a), showing widespread
sequence variability at almost every position in the AT domains,
except for the residues near the substrate binding site (Figure
S7b). Mutations in KS domains, on the other hand, are mostly
restricted to the regions in vicinity (around the core) of the
substrate-binding site and the dimerization interface (Figure S7c),
suggesting their importance in influencing substrate selectivity.
An unexpectedly large role for concerted evolution
Concerted evolution is not peculiar to the rapamycin family
(Figure S8). For the gene clusters encoding the biosynthesis of the
mutually closely related macrolides erythromycin [31], oleando-
mycin [32] and pikromycin [33], BGC-specific branching
appeared to occur for both KS and AT domains, similar
to the pattern for rapamycin, FK520, meridamycin and
pladienolide. However, for the ansamycin antibiotics macbecin
[34], geldanamycin [35] and herbimycin [36], and the antifungals
pimaricin [37], nystatin [38] and amphotericin [39], BGC-specific
branching occurs only for AT domains, and not for KS domains.
Finally, corroborating earlier observations [40], domains from the
trans-AT PKS gene clusters encoding pederin [41] and psymberin
[42] do not show any BGC-specific branching at all. We observed
that certain NRPS gene clusters also show signs of concerted
evolution: a clear BGC-specific branching pattern pointing to
concerted evolution can be seen for the A domains and most of the
C domains of the gene clusters encoding the biosynthesis of the
closely related calcium-dependent lipopeptides daptomycin [23],
A54145 [43] and CDA [44]. However, the glycopeptide gene
clusters encoding the biosynthesis of balhimycin [45], teicoplanin
[46] and A40926 [47] showed no such pattern at all: almost all
domains cluster in groups corresponding to domains in the same
positions in the assembly line. Collectively, these observations
suggest that concerted evolution is a key mechanism driving the
evolution of NRPS and PKS gene sequences, but the extent to
which it happens depends on family-specific functional constraints
as well as on the presence of other evolutionary forces acting upon
a gene cluster. Our qualitative model of PKS/NRPS evolution
(Fig. 4), which summarizes the interplay of concerted evolution
with other evolutionary mechanisms, is relevant to PKS/NRPS
engineering efforts: the highly homologous sets of domains
generated by concerted evolution are more likely to be mutually
interoperable than domain sets chosen at random, and might
therefore be attractive building blocks for synthetic biological
engineering of biosynthetic pathways.
Distinct mechanisms of PKS/NRPS BGC evolution
To understand more generally how PKS and NRPS BGCs
evolve, we set out to measure the contributions of concerted
evolution, duplication, and divergence to the evolution of all
multimodular PKS and NRPS BGCs in both our known and
predicted BGC data sets. We first collected and quantified 25
different features describing the nature of gene cluster sequences
and the relationships among their constituent domains (see
methods for details). A principal component analysis (PCA) and
hierarchical clustering using these features can distinguish many of
the well-known gene cluster families from our data set of known
BGCs (Figure S9, Fig. 5a). Two features in particular, the
‘internal similarity index’ and the ‘vertical evolution index’,
explain much of the variation in terms of the modes of evolution
of different classes of gene clusters (Fig. 5b). At the level of
individual domains, we find that there are four primary
mechanisms by which NRPS and PKS BGCs evolve (Fig. 5c–f,
Figure S10). Firstly, gene clusters encoding glycopeptides,
calcium-dependent lipopeptides and macrolides/polyethers ap-
pear to be most repetitive, pointing to a history of module
duplications and/or a prominent influence of concerted evolution.
The syringopeptin NRPS [48] and mycolactone PKS [49] are
extreme examples of this: both are likely to have evolved recently
by subsequent module duplications and concerted evolution.
Secondly, we sometimes observed gradients of the internal
homology p-values from the N- to C-termini of large synthases,
suggesting that some gene clusters evolve to encode the synthesis of
larger molecules by iterative duplication of their most N-terminal
module, would have the effect of extending an intermediate NRP
or PK by the addition of a new starter unit. Thirdly, a group of
BGCs including the ones that encode the polyketides psymberin
[42] and erythrochelin [50] show a ‘vertical’ type of evolution, in
which the domains appear to evolve independently, with perhaps
occasional domain swapping with related gene clusters, as has
been suggested previously [40]. Finally, there are many gene
Computational Analysis of Biosynthetic Gene Cluster Evolution
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clusters showing a ‘mixed’ mode of evolution, in which one or
more of the above mechanisms are combined. For example, NRP
siderophore gene clusters show some signs of internal recombina-
tions, but at the same time many domains show no high mutual
similarity. Like the trans-AT PKS gene clusters, they seem to have
a higher tendency to recruit domains from dissimilar gene clusters.
This recruitment over larger evolutionary distances appears to be
a general feature of NRPS gene clusters as opposed to PKS gene
clusters, and might be related to the wider range of possible
substrates for NRPSs, which often require BGC-specific sub-
pathways for the synthesis of a dedicated monomer [51].
Birth and death of biosynthetic gene clusters during
evolution
The observation of so many different evolutionary mechanisms
of gene cluster evolution begs the question which circumstances
lead to the birth and death of BGCs over evolutionary time. Are
all BGCs that are detected bioinformatically also still intact and
functional, or might many of them have degenerated and entered
a nonfunctional state? The absence or presence of nonfunctional
genetic units (e.g., pseudogenes or pseudo-gene-clusters) is largely
governed by the evolutionary population dynamics of the species.
Many bacteria live in large effective population sizes and have
relatively short generation times, leading to very strong purifying
selection and, consequently, rigorous genome streamlining [52].
Hence, BGCs that become nonfunctional will be quickly lost in
such organisms if they do not provide any evolutionary advantage.
Notably, some bacteria in fact occur in smaller population sizes
and/or regularly go through population bottlenecks, leading to
altogether different evolutionary dynamics [53]: in such cases, a
range of pseudogenized gene clusters can sometimes still be
observed that have not been purged from the genome yet [54]. On
the whole, however, these appear to be rather the exception than
the rule [55].
Concerning the birth of new gene cluster architectures, large
effective population sizes and short generation times also suggest
that BGC modifications should immediately confer an evolution-
ary advantage in order to be maintained; on the other hand,
frequent changes in population size may affect the probability of
mutations to be fixated in the population [56]. Alternatively,
neutral mutations could hitchhike with strongly adaptive muta-
tions within or close to the same gene cluster. Concerning the
physical growth of gene clusters, it should be noted that new
enzymes may already be recruited to a biosynthetic pathway
before their genes are physically recruited to the gene cluster, and
such an addition to a pathway could evolve through, e.g., positive
selection acting on promiscuous enzyme activities or substrate
specificities [57]. The precise reason for and evolutionary
mechanism of clustering of biosynthetic genes in bacteria itself is
still largely an unanswered question [58].
Implications for biosynthetic engineering
Our analysis of BGC evolution will enable new approaches to
BGC engineering informed by the mechanisms by which BGCs
evolve naturally. Our results suggest that efforts to engineer the
biosynthesis of unnatural natural products could be more
successful by observing the modes by which specific BGC classes
evolve in nature.
For example, conglomerate molecules consisting of multiple
different chemical moieties could be designed by engineering
BGCs consisting of novel combinations of sub-clusters. Such an
effort could be guided by information taken from evolutionary
Figure 4. Qualitative model for the evolution of NRPS/PKS domains. After modules are duplicated, they may get ‘trapped’ in a cycle in which
small sequence divergences are counterbalanced by internal recombinations that drive concerted evolution. Through strong diversifying selection (or
sufficient drift), domains may break out of this cycle towards domain sequences that are protected from concerted evolution by functional
divergence and subsequent stabilizing selection on the new function, or by reduced internal recombination rates due to larger sequence differences
between the domains. The abovementioned sequence divergence may occur through cumulative mutation or through recombination with other
gene clusters (or other modules within the same gene cluster).
doi:10.1371/journal.pcbi.1004016.g004
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comparisons, which would offer suggestions about which sub-
clusters are most likely to function together, based on how often
evolution has successfully forged combinations between them.
Furthermore, our evolutionary analysis of NRPS and PKS gene
clusters suggests that concerted evolution has created sets of
domains within gene clusters that are highly homologous. These
domain sets are more likely to be mutually interoperable than
domain sets chosen at random, and might therefore be of great
utility in future engineering efforts.
Also, evolutionary strategies towards generating larger and
more complex compounds could be mimicked by N-terminally
extending certain types of NRPS/PKS gene clusters by duplicat-
ing and then carefully modifying the first assembly-line module.
Overall, in combination with new synthetic biology techniques
that may soon enable the rapid assembly of thousands of clusters
from a common set of parts [59–61], our results suggest a new
approach for re-engaging gene cluster engineering in a manner
informed by the mechanisms by which gene clusters have naturally
evolved.
Methods
Comparison of HGT with primary metabolism
To remove highly similar genomes from these analyses, we used
the AMPHORA [62] (August 10th, 2010) dataset, which contains
gene sequences from 562 organisms for 30 universally conserved
genes. Genes from these organisms were compared using sequence
identities based on MUSCLE [63] multiple sequence alignments.
This resulted in 30 distances between each pair of organisms. The
distributions of distances of all pairs were tested for normality
using a Shapiro-Wilk test. An organism distance map was then
built with distances defined as the mean distances of AMPHORA
Figure 5. Diverse and distinct modes of evolution for PKS and NRPS BGCs. a, Scatter plot showing the first two principal components
resulting from a PCA analysis of different evolutionary characteristics of BGCs encoding different classes of NRPs and PKs. The first two principal
components describe 63% of the variance. BGCs encoding members of the same family (e.g., lipopeptides, glycopeptides or macrolides) tend to
cluster together, suggesting that their family members evolve in similar ways, while different families cluster apart from each other, suggesting
distinct modes of evolution. Colors indicate distinct classes of BGCs. b, Scatter plot showing two features of BGCs – internal similarity index and
vertical evolution index – that, of the 25 measured features, underlie most of the variation. The internal similarity index indicates how similar domains
in a BGC are to other domains within the same BGC. The vertical evolution index indicates how closely related a BGC is to the BGCs harboring the
closest relatives of its constituent domains (see Methods for more details). Colors indicate distinct classes of BGCs, as in panel a. c–f, Domain
architecture plots of PKSs and NRPSs show distinct modes of evolution: c, Internal duplication with concerted evolution; d, N-terminal additions by
module duplication and recombination; e, domain swapping with other BGCs; and f, mixed evolution. Geometric shapes indicate domain types (see
legend); domain colors indicate the internal homology p-value of each domain to its closest relative within the same gene cluster, within the total
distribution of all similarities between domains of the same type in the entire data set: hence, domains colored red are most similar, while domains
colored blue are most dissimilar.
doi:10.1371/journal.pcbi.1004016.g005
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genes. The resulting distance map was clustered using default
settings in MCL [64], and only one member of each cluster was
kept for further analyses. This left us with total of 408 organisms.
To search for histidine and tryptophan biosynthetic operons, we
modified ClusterFinder [8]. Pfam [65] IDs associated with the
histidine biosynthesis pathway (PF00475, PF00815, PF01174,
PF01502, PF01634, PF04864, PF08029, and PF08645) or with the
tryptophan biosynthesis pathway (PF00218, PF00290, PF00465,
PF00697, PF01220, PF01264, PF01487, PF04715, and PF08501)
were acquired from JGI IMG [66]. Trp or His operons were
defined as gene clusters containing at least one of these domains
with a probability .0.5 and containing at least two of the domains
in total. Among 408 organisms searched, 350 His and 288 Trp
biosynthesis operons were identified in 271 and 248 different
organisms, respectively. The average number of domains per
predicted gene cluster were 2.9 and 3.1, respectively.
Best matching sequence homologs of a query protein domain
from a biosynthetic or primary metabolic gene cluster were
obtained using MUSCLE [63] multiple sequence alignments. The
distance between the organism containing the query protein
domain and the organism with the best matching sequence
homolog was determined based on 16S rRNA sequence similarity.
Best matching sequence homologs of all protein domains that are
in Pfam are included in the organism similarity histograms
(Fig. 1a).
Phylogenetic profiling
For each BGC, a two-dimensional array of the size correspond-
ing to the numbers of consecutive protein domains that are in
Pfam database (rows) and 408 selected organisms (columns) (see
‘‘Comparison of HGT with primary metabolism’’) was created.
The cells in the array consisted of sequence identities between a
given domain from a BGC and the most homologous domain
(which is also predicted as part of a BGC) from a given organism.
Next, we calculated a Pearson product-moment correlation
coefficient (correlation coefficient) for each possible pair of protein
domains (rows), resulting into a new matrix, a correlation matrix,
of the size corresponding to the number of protein domains (rows
from the initial array) in both dimensions. To take rearrangements
into account, we reordered rows and columns of the correlation
matrix based on hierarchical clustering of the correlation matrix in
both dimensions. We then parsed linear motifs that are likely to
evolve in a correlated fashion by selecting consecutive pairs of
domains in this reordered correlation matrix (consecutive fields on
the first offset diagonal) with correlation coefficient .0.5. The
analysis was repeated by setting the correlation coefficient cutoff to
.0.65 and .0.8. Each motif was divided into all possible sub-
motifs of sizes between 2 domains and the total number of
domains in a motif. To determine the significance of a (sub)motif
occurrence, we next compared the number of (sub)motif
occurrences to the number of all possible (sub)motif occurrences
in all BGCs that did not pass the correlation coefficient cutoff.
Pearson’s x2 test with Bonferroni correction was applied to test for
statistical significance, with the null hypothesis stating that the two
values are equal.
Analysis of recent evolution of BGCs
We performed an all-versus-all alignment of nucleotide
sequences of known and predicted BGCs using the blastn
algorithm. Gene cluster sequences were divided into blocks of
1 kb, and then mapped to the most homologous blocks from other
gene clusters, as well as from the same gene cluster (to test for
genomic duplications). 56% of the blocks (118,320 out of 212,176)
did not map to any homologous regions in the same or other
BGCs with .70% identity. Evolutionary events (insertions/
deletions, duplications and rearrangements) were detected by a
custom-made Python script (Data S1) comparing each alignment
of two-gene clusters having at least three matching blocks with .
70% identity. Rearrangements were defined as an identified
difference in the order of 1-kb blocks in an otherwise conserved
(piece of) gene cluster, such as when A1-A2-A3-A4-A5 matches to
B1-B4-B3-B2-B5 in an alignment of two BGCs A and B. Indels
were defined as 1-kb blocks present in one gene cluster but not in
the other gene cluster, such as when A1-A2-A3-A4-A5-A6
matches to B1-B2-B5-B6 in an alignment. To make these
inferences more reliable, a constraint was used that the flanking
regions (of size .= 2 kb) of each indel breakpoint must be
homologous between query and hit gene cluster, and the block
order must be conserved between them. Finally, duplications were
defined as 1-kb blocks that had the best hit towards another block
in its own gene cluster, and having a higher copy number in one
gene cluster than in the other, such as when A1-A2-A3-A2-A3-A4-
A5 aligns to B1-B2-B3-B4-B5, while the mutual sequence identity
between the A2 and A3 pairs is higher than between any of the
A2/A3 blocks and B2 or B3.
Comparison of sequence vs. structural similarity of gene
clusters and their products
For a given BGC pair, we first calculated sequence identities
between all Pfam domain pairs of each Pfam ID, using MUSCLE
[63] multiple sequence alignments. A BGC sequence similarity
index was defined as the Jaccard index with the size of the
intersection represented by the number of Pfam pairs whose
sequence identities were higher than the best 10% alignments of
all Pfam domains of the same Pfam ID. Taking into account the
underlying distributions of sequence identities between all domain
sequences prevented misinterpretation of simpler sequence simi-
larity metrics (e.g., an absolute sequence identity threshold) when
different evolutionary rates apply to different protein families. We
define structural similarity of a given BGC product pair as the
Tanimoto coefficient between the two SMILES strings, using
linear-path fingerprints (FP2) from Open Babel [67].
Sub-cluster analysis of known gene clusters
Sub-clusters with known functions from experimentally charac-
terized gene clusters were manually collected from the literature.
Sub-cluster sharing between gene clusters from the training set was
calculated using blastp [68]. The minimum requirement used to
identify a shared sub-cluster between two BGCs was sharing either
75% of the genes with .45% average sequence identity, 50% of
the genes with .50% average sequence identity, or 25% of the
genes with 70% identity. To account for different modes of
sequence evolution of different sub-cluster types, these values were
adjusted with sub-cluster type-specific cutoffs to obtain a good
match between genetic similarity and chemical similarity (Table
S3). The final sub-cluster sharing network was drawn with
Cytoscape [69].
Multimodular NRPS/PKS gene cluster evolution
To study patterns of evolution in multimodular NRPS and PKS
gene clusters, a range of features was calculated describing key
characteristics of these gene clusters. The first set of features was
based on the topologies of intra-BGC domain similarity networks
(with protein domains and sequence similarity representing nodes
and edges, respectively) and consisted of the average clustering
coefficient, average sequence similarity, graph transitivity, number
of 2–4 node cliques, number of connected components in a graph
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with sequence similarity .50%, and average neighbor degree. We
also included as features the number of different Pfam domain
types in a BGC, the total number of domains in a BGC, the
average number of domains per gene, and the averages and
standard errors of best-matching pair sequence identities and
internal BGC similarity indices. Two evolutionary indices were
also added: the internal similarity index and the vertical evolution
index. To obtain the internal similarity index of a gene cluster, we
calculated for each of its NRPS/PKS domains the p-value of its
closest blastp match inside the gene cluster, given the distribution
of the percent identities of all within-gene-cluster blastp hits of all
domains of that domain type in the complete set of gene clusters.
The internal similarity index was then calculated from these
numbers as the mean of all inverse p-values. The same inverse p-
values were used for plotting the internal domain similarity across
gene clusters. The vertical evolution index of a gene cluster was
calculated as the average difference between the p-value of the top
10 percent identities of a domain’s blastp hits to all domains from
other gene clusters with the p-values of the Lin distances of the
gene clusters to the host gene clusters of each of the top 10 hit
domains. Consequently, gene clusters with domains with highly
similar closest hits to domains in dissimilar gene clusters get a low
value, while gene clusters with domains with dissimilar closest hits
to domains in similar gene clusters get a high value.
PCA analysis was performed with the aforementioned features
as an input. Compound types were assigned using the classifica-
tions taken from the primary literature.
Supporting Information
Figure S1 The rapid and dynamic evolution of BGCs
differs from the evolution of tryptophan operons.
Distributions of the best matching sequence homologs with respect
to organism similarity (based on 16S rRNA) for predicted BGCs
and tryptophan operons suggest significant differences in the ways
they evolve, The distribution of all organism-organism similarities
(background organism similarities) is trimodal, which may explain
why, similarly, the distributions of the best-matching sequence
homologs for predicted BGCs and tryptophan operons are also
trimodal.
(PDF)
Figure S2 Examples of insertions/deletions in BGCs.
Three gene cluster alignments of highly similar BGCs (.70% at
the nucleotide level) are shown that are likely to represent
relatively recent insertions/deletions in BGCs with functional
consequences. In the upper panel, genes that putatively encode
one or more sugar moieties have been inserted/deleted from a
saccharide biosynthesis gene cluster. In the middle panel, a
germacradienol synthase has been replaced by another type of
terpene synthase, a pentalenene synthase, as well as an AMP-
dependent synthetase. In the lower panel, a gene cluster related to
the well-known coelibactin gene cluster from Saccharopolyspora
spinosa is shown, which has acquired a MSAS polyketide synthase,
a cytochrome P450, a carboxamide synthase and a 3-oxoacyl-
(ACP) synthase compared to the coelibactin gene cluster from
Streptomyces coelicolor. These genes are predicted to encode a
polyketide moiety that might be attached to the NRP siderophore
synthesized by the coelibactin NRPS machinery.
(PDF)
Figure S3 Phylogeny of ansamycin KS domains. A
FastTree [70] phylogenetic tree of all KS domains from the
divergolide, hygromycin, maytansinoid, rubradirin, rifamycin and
macbecin gene clusters (which all have an AHBA sub-cluster), was
generated with the 10 closest BLAST hits of each domain (outside
those to KS domains within the same data set, and after removal
of redundancy). Except three, all KS domains cluster mono-
phyletically with other ansamycin KS domains (i.e., other KS
domains from gene clusters with an AHBA sub-cluster). Other
related KS domains cluster in separate clades.
(PDF)
Figure S4 Phylogenetic tree of MSA/OSA iterative
PKSs. Maximum likelihood phylogenetic tree (constructed with
RAxML [71]) of all known bacterial naphthoic acid/6-methylsa-
licylic acid/orsellinic acid synthases, with a fungal 6-methylsa-
licylic acid synthase used as outgroup. The core scaffold/type of
the parent BGC in which the MSAS/OSAS sub-cluster resides is
denoted with colored squares at the right.
(PDF)
Figure S5 Similarity between daptomycin and its BGC
and other BGCs and their small molecule products. Node
sizes correspond to the number of Pfam domains with sequence
identity to one of the daptomycin genes higher than the top 10th
percentile of the background Pfam sequence identity distribution,
and node colors denote the average sequence identity for such
Pfam domain pairs.
(PDF)
Figure S6 GPL condensation domains clade with dap-
tomycin condensation domains in a phylogenetic tree.
The tree shown was reconstructed using the maximum likelihood
method in MEGA [72], after structure-based multiple sequence
alignment with PROMALS3D [73]. The C-domain of the GPL
starter module clades together with the C-domain of the
daptomycin starter module, and the other GPL C-domains clade
together with the DCL C-domains from the daptomycin assembly
line. A C-domain of the glycopeptide balhimycin (which is closely
related to vancomycin) also groups with these domains.
(PDF)
Figure S7 Mutations in AT and KS domains mapped
onto their crystal structures. a, We aligned sequences of AT
and KS domains from 4 BGCs (Fig. 3a) on a crystal structure of a
KS-AT didomain from module 3 of the 6-deoxyerthronolide B
synthase (PDB ID: 2QO3) [74]. For each position in the
alignment, we assessed sequence variability by calculating entropy
based on the amino acid frequencies (color-coded from white to
red in chain A; chain B of the homodimer is shown as backbone
trace only). b, While most of the domain shows a high tendency
towards mutations, visual inspection reveals a relatively conserved
region at the acetate-binding site of the AT domain. c, Mutations
in the KS domain, however, appear to cluster in several regions of
the structure, including the region around the substrate-binding
site (here, denoted by the binding site of the inhibitor cerulenin)
and at the homodimer interface. The entropy was not calculated
in the regions that fall outside of the Pfam-annotated domains, nor
in the indel-rich regions (marked black). The figures were
generated using UCSF Chimera [75].
(PDF)
Figure S8 Evidence for concerted evolution in various
PKS and NRPS gene clusters. Phylogenetic trees of KS/AT
and C/A domains, respectively, involved in the biosynthesis of
several families of related polyketide or nonribosomal peptide
molecules show various degrees of concerted evolution. For
example, trees of the AT and KS domains of macrolide
biosynthesis enzymes show a high rate of BGC-specific branching
(suggestive of concerted evolution), while hardly any such
branching is observed in trees of the C and A domains of
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glycopeptide biosynthetic enzymes. Phylogenetic trees were
constructed in MEGA5 [72] with the neighbor-joining method
(100 bootstrap replicates), based on alignments of the domain
amino acid sequences generated with MUSCLE [63]. For tree
construction, all positions containing gaps and missing data were
eliminated.
(PDF)
Figure S9 Clustered heat map of features based on
protein sequence alignments and domain-similarity
network topologies. Features include the average number of
Pfam domains per gene, means and standard deviations of the
clustering coefficient and the network transitivity (see Methods for
more details). At least four distinct clusters of BGCs appear from
the heat map that have different evolutionary characteristics.
(PDF)
Figure S10 Domain architectures of all 658 BGCs
encoding multimodular PKS and NRPS enzymes. The
domains are colored by the p-value of the homology to their
nearest neighbor within the same gene cluster. BGCs that are
mostly red contain domains that are highly similar to other
domains in the same gene cluster, whereas BGCs that are mostly
blue contain domains that are dissimilar from other domains
within the same gene cluster.
(PDF)
Figure S11 Detailed phylogenetic trees of KS and AT
domains of polyketide synthases from the rapamycin
family. The tree was reconstructed using the neighbor-joining
method in MEGA [72], using 100 bootstrap replicates.
(PDF)
Table S1 Overview of evolutionary events detected
between alignments of gene cluster pairs sharing at
least three matching 1 kb-sized blocks in alignments
with thresholds of .70% identity (top) or .80% identity
(bottom). The numbers of observed indels, duplications and
rearrangements are given for BGCs of several sizes classes: 1–
10 kb, 11–20 kb, 21–30 kb, 31–40 kb and 40+ kb, or in
cumulative combinations of these size classes (.10 kb, .20 kb,
.30 kb, .40 kb).
(XLSX)
Table S2 Results from the phylogenetic profiling anal-
ysis at three different cross-correlation cutoffs. The first
and second column of each table show a number of co-evolving
and non-coevolving motifs, followed by p-values from a Chi2-test
(in which the first two numbers were assumed to be equally
distributed), a string of Pfam IDs that constitute a motif, and their
description.
(XLSX)
Table S3 Sub-cluster type-specific cut-offs to determine
sub-cluster sharing between BGCs. Suitable cut-offs were
determined by a manual comparison of known sub-clusters to their
corresponding known chemical moieties, and cut-offs were set at
those sequence identities where the chemistry produced by the
enzymes encoded by the sub-clusters was (nearly) identical.
(XLSX)
Data S1 Python script and associated data files that
were used to identify insertions/deletions, duplications
and rearrangements in homologous gene clusters.
(ZIP)
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